Stay updated with breaking news from Bio Techne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Paradigm Strategies in Wealth Management LLC raised its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 284.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 4,373 shares of the biotechnology company’s stock after purchasing an additional 3,237 shares during the quarter. […]
StockNews.com cut shares of Bio-Techne (NASDAQ:TECH – Get Rating) from a buy rating to a hold rating in a report issued on Friday. A number of other equities research analysts also recently weighed in on TECH. KeyCorp dropped their price target on shares of Bio-Techne from $125.00 to $115.00 and set an overweight rating for […]
First PREMIER Bank grew its stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 300.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,200 shares of the biotechnology company’s stock after buying an additional 900 shares during the period. First […]
Read independent reviews on Proteome Profiler Mouse XL Cytokine Array from Bio-Techne on SelectScience
Bio-Techne products, product reviews and application articles on SelectScience.